Epigenetic Therapeutic Targets Summit
Evvnt Promotion / evvnt
Archive
13.07.2021 - 15.07.2021 Virtual
Time: 1:00 pm - 4:00 pm
Conference themes
Returning for its second year, the virtual Epigenetic Therapeutic Targets Summit is the first-ever industry forum dedicated exclusively to the frontier of drug development in epigenetics.
The two-day program will enable you to:
Explore the full spectrum oncological and non-oncological applications of genetic regulation therapeutics that is being investigated to identify new unmet clinical needs that epigenetics could be central to treating.
Returning for its second year, the virtual Epigenetic Therapeutic Targets Summit is the first-ever industry forum dedicated exclusively to the frontier of drug development in epigenetics.
The two-day program will enable you to:
Explore the full spectrum oncological and non-oncological applications of genetic regulation therapeutics that is being investigated to identify new unmet clinical needs that epigenetics could be central to treating.
Professional congress organizer (PCO)
Hanson Wade
Hanson Wade
Notes
Brochure: https://go.evvnt.com/742339-3?pid=4832
Speakers: Ellen Filvaroff, Executive Director in Translational Development, Bristol-Myers Squibb, Elisabetta Chiarparin, Director - Medicinal Chemistry, AstraZeneca and more
Brochure: https://go.evvnt.com/742339-3?pid=4832
Speakers: Ellen Filvaroff, Executive Director in Translational Development, Bristol-Myers Squibb, Elisabetta Chiarparin, Director - Medicinal Chemistry, AstraZeneca and more
Enquiries and Registration:
https://go.evvnt.com/742339-2?pid=4832
Mr. Customer Service
General Medicine
Languages
English
English
Congress fees
USD 1499.00 - USD 2498.00
USD 1499.00 - USD 2498.00
Participants expected
1000
1000
Organizer contact info
83 Great Titchfield Street
W1W 6RH London
United Kingdom
83 Great Titchfield Street
W1W 6RH London
United Kingdom
"Going International promotes access to education and training for all regardless of social, geographic and national borders."
